12/29/2023 0 Comments Cgm findings vs![]() Dr Pop-Busui reported receiving personal fees from Averitas, Nevro, Novo Nordisk, Boehringer Ingelheim, and Bayer and grants from AstraZeneca outside the submitted work. Dr Peters reported serving on advisory boards for Abbott Diabetes Care, Eli Lilly, Medscape, Novo Nordisk, and Zealand receiving nonfinancial study supplies from Abbott Diabetes Care and owning stock options for Omada Health and Teladoc. Dr Calhoun reported being a former employee of Dexcom Inc and his current employer receiving consulting payments on his behalf from vTv Therapeutics, Beta Bionics, and Diasome. Ms Ruedy reported receiving grants to her institution from Tandem Diabetes Care and Beta Bionics and study supplies from Novo Nordisk and Eli Lilly outside the submitted work. Dr Beck reported his institution receiving grant funding and study supplies from Tandem Diabetes Care and Beta Bionics study supplies from Medtronic, Ascencia, and Roche consulting fees and study supplies from Eli Lilly and Novo Nordisk and consulting fees from Insulet, Bigfoot Biomedical, vTv Therapeutics, and Diasome. Dr Martens’ employer has a pending patent for Ambulatory Glucose Profile (issued to the International Diabetes Center). Additionally, Dr Martens’ employer has received funds on his behalf for research and speaking support from Dexcom, Abbott Diabetes Care, Medtronic, Insulet, and Novo Nordisk funding for speaking support from Medscape, American Diabetes Association, American Medical Group Association, and American College of Physicians funding for publication support from American College of Physicians and Eli Lilly and consulting support from Bigfoot Biomedical outside the submitted work. Dr Martens’ employer, International Diabetes Center, participated in this study as a study site and was reimbursed for that participation by grant funding (Dexcom sponsor) during the conduct of the study. Supervision: Beck, Ruedy, Peters, Young, Orozco, Biggs, Bergenstal.Ĭonflict of Interest Disclosures: All authors received grant funding from Dexcom to their institution for the conduct of the submitted study. doi:10.1001/jama.2021.7444Īuthor Contributions: Dr Beck had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Ĭoncept and design: Beck, Ruedy, Peters, Pop-Busui, Philis-Tsimikas, Umpierrez, Kruger, Young, Aleppo, Polonsky, Price, Bergenstal.Īcquisition, analysis, or interpretation of data: Martens, Beck, Bailey, Ruedy, Calhoun, Peters, Pop-Busui, Philis-Tsimikas, Bao, Davis, Bhargava, McGill, Nguyen, Orozco, Biggs, Lucas, Buse, Price, Bergenstal.ĭrafting of the manuscript: Martens, Beck, Bailey, Peters, Philis-Tsimikas, Price, Bergenstal.Ĭritical revision of the manuscript for important intellectual content: All authors.Īdministrative, technical, or material support: Martens, Beck, Ruedy, Bao, Orozco, Biggs, Price, Bergenstal. ![]() Beck, MD, PhD, Jaeb Center for Health Research Foundation, Inc, 15310 Amberly Dr, Ste 350, Tampa, FL 33647 ( for Publication: April 23, 2021.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |